2o5d: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:2o5d. | {{Seed}} | ||
[[Image:2o5d.png|left|200px]] | |||
<!-- | <!-- | ||
| Line 9: | Line 10: | ||
{{STRUCTURE_2o5d| PDB=2o5d | SCENE= }} | {{STRUCTURE_2o5d| PDB=2o5d | SCENE= }} | ||
===Thiazolone-acylsulfonamides as novel HCV NS5B polymerase allosteric inhibitors: Convergence of structure-based drug design and X-ray crystallographic study=== | |||
<!-- | |||
The line below this paragraph, {{ABSTRACT_PUBMED_17276060}}, adds the Publication Abstract to the page | |||
(as it appears on PubMed at http://www.pubmed.gov), where 17276060 is the PubMed ID number. | |||
--> | |||
{{ABSTRACT_PUBMED_17276060}} | |||
==About this Structure== | ==About this Structure== | ||
| Line 29: | Line 33: | ||
[[Category: Structure-based drug design]] | [[Category: Structure-based drug design]] | ||
[[Category: Viral rna-directed rna polymerase]] | [[Category: Viral rna-directed rna polymerase]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | |||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 20:41:59 2008'' | |||